Log in to save to my catalogue

A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavale...

A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavale...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5651219

A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

About this item

Full title

A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2017-10, Vol.35 (45), p.6228-6237

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights•Pentavalent reassortant rotavirus vaccine was tested for efficacy in infants. •The vaccine (BRV-PV) showed excellent tolerability and a good safety profile. •Primary analysis efficacy was 36% against SRVGE and up to 60.5% against VSRVGE. •The efficacy through 2 years of age was 39.5% (SRVGE) and 54.7% (VSRVGE). •The intent to treat analy...

Alternative Titles

Full title

A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5651219

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5651219

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2017.09.014

How to access this item